Ajanta Pharma has announced its participation in two upcoming investor conferences to engage with analysts and institutional investors. These meetings serve as platforms for the company to provide updates on its business operations and strategic outlook. The company has confirmed that discussions during these scheduled interactions will be strictly limited to information that has already been made available to the public.
Investor Engagement Schedule
Ajanta Pharma is set to participate in a series of engagements with the investment community. These meetings are intended to facilitate transparent communication with analysts and institutional investors regarding the company’s progress and market position. The scheduled sessions are as follows:
- May 29, 2026: ICICI Securities India Investor Conference (Group/One-on-One at Grand Hyatt, Santacruz).
- June 8, 2026: 360 ONE Capital (B&K) Annual Investor Conference.
Important Considerations
The company has noted that this schedule is subject to change based on exigencies that may arise for either party. Ajanta Pharma remains committed to governance standards by ensuring that all interactions remain focused on existing public disclosures. No unpublished price-sensitive information will be shared during these sessions.
Source: BSE
